Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Alpine Immune Sciences stock
Learn how to easily invest in Alpine Immune Sciences stock.
Alpine Immune Sciences Inc is a biotechnology business based in the US. Alpine Immune Sciences shares (ALPN) are listed on the NASDAQ and all prices are listed in US Dollars. Alpine Immune Sciences employs 85 staff and has a trailing 12-month revenue of around $32 million.
How to buy shares in Alpine Immune Sciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ALPN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Alpine Immune Sciences stock price (NASDAQ: ALPN)Use our graph to track the performance of ALPN stocks over time.
Alpine Immune Sciences shares at a glance
|Latest market close||$6.89|
|52-week range||$6.00 - $14.40|
|50-day moving average||$8.22|
|200-day moving average||$8.94|
|Wall St. target price||$21.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.75|
Buy Alpine Immune Sciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Alpine Immune Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Alpine Immune Sciences price performance over time
|1 week (2022-09-19)||-8.86%|
|1 month (2022-08-26)||-13.88%|
|3 months (2022-06-24)||-20.80%|
|6 months (2022-03-22)||N/A|
|1 year (2021-09-24)||-33.49%|
|2 years (2020-09-25)||-15.77%|
|3 years (2019-09-26)||75.77%|
|5 years (2017-09-26)||11.11|
Alpine Immune Sciences financials
|Revenue TTM||$32 million|
|Gross profit TTM||$-35,299,000|
|Return on assets TTM||-17.5%|
|Return on equity TTM||-75.73%|
|Market capitalisation||$303.2 million|
TTM: trailing 12 months
Alpine Immune Sciences share dividends
We're not expecting Alpine Immune Sciences to pay a dividend over the next 12 months.
Have Alpine Immune Sciences's shares ever split?
Alpine Immune Sciences's shares were split on a 1:4 basis on 24 July 2017. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alpine Immune Sciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Alpine Immune Sciences shares which in turn could have impacted Alpine Immune Sciences's share price.
Alpine Immune Sciences share price volatility
Over the last 12 months, Alpine Immune Sciences's shares have ranged in value from as little as $6 up to $14.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alpine Immune Sciences's is 1.5881. This would suggest that Alpine Immune Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Alpine Immune Sciences overview
Alpine Immune Sciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. .
Alpine Immune Sciences in the news
Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors
Alpine Immune Sciences raising $100M in public offering
Alpine Immune Sciences Announces Pricing of $100 Million Public Offering
Frequently asked questionsWhat percentage of Alpine Immune Sciences is owned by insiders or institutions?
Currently 6.942% of Alpine Immune Sciences shares are held by insiders and 54.959% by institutions. How many people work for Alpine Immune Sciences?
Latest data suggests 85 work at Alpine Immune Sciences. When does the fiscal year end for Alpine Immune Sciences?
Alpine Immune Sciences's fiscal year ends in December. Where is Alpine Immune Sciences based?
Alpine Immune Sciences's address is: 188 East Blaine Street, Seattle, WA, United States, 98102 What is Alpine Immune Sciences's ISIN number?
Alpine Immune Sciences's international securities identification number is: US02083G1004 What is Alpine Immune Sciences's CUSIP number?
Alpine Immune Sciences's Committee on Uniform Securities Identification Procedures number is: 02083G100
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert